全表观基因组关联研究揭示与甲状腺功能相关的CpG位点及其对KLF9的调控作用
本研究对甲状腺激素与DNA甲基化的关联进行了固定效应Meta分析,纳入ThyroidOmics联盟8个队列最多7073名欧洲和非洲裔参与者,发现游离甲状腺素、游离三碘甲状腺原氨酸和促甲状腺激素分别与3、5、2个CpG位点在全表观基因组水平显著关联并复制,孟德尔随机化支持甲状腺状态对KLF9 DNA甲基化的因果效应。
要点
- 发现并复制了与游离甲状腺素、游离三碘甲状腺原氨酸和促甲状腺激素相关的多个CpG位点,包括KLF9和DOT1L。
- 孟德尔随机化分析支持甲状腺状态对KLF9 DNA甲基化的因果效应。
- KLF9的cg00049440甲基化与KLF9基因表达呈负相关。
核心结论
- 报告了促甲状腺激素、甲状腺激素与血液DNA甲基化之间的新关联,尤其涉及KLF9,并证明整合全表观基因组关联研究与其他组学数据有助于揭示人类甲状腺激素信号。
研究设计与样本
- 研究为固定效应Meta分析的全表观基因组关联研究,纳入ThyroidOmics联盟8个队列最多7073名欧洲和非洲裔参与者,采用发现和复制阶段。
- 统计模型以标准化beta CpG值为因变量,分别以对数转换的促甲状腺激素、游离甲状腺素和游离三碘甲状腺原氨酸为自变量进行线性回归。
- 复制的发现与全血基因表达水平进行相关性分析,并通过两样本孟德尔随机化检验促甲状腺激素和游离甲状腺素的因果影响。
主要发现
- 发现并复制了全表观基因组显著关联(p值<1.1E-7):游离甲状腺素3个CpG、游离三碘甲状腺原氨酸5个CpG、促甲状腺激素2个CpG(合并p值=1.5E-9至4.3E-28)。
- 关联包括注释到KLF9(cg00049440)和DOT1L(cg04173586)的CpG位点,与所有三种甲状腺性状重叠。
- 还发现游离甲状腺素与FKBP5的CpG、游离三碘甲状腺原氨酸与CSNK1D/LINCO1970和LRRC8D的CpG显著关联。
- 孟德尔随机化分析支持甲状腺状态对KLF9 DNA甲基化的因果效应;KLF9的cg00049440甲基化与全血KLF9基因表达呈负相关。
- CSNK1D/LINC01970的CpG与肝细胞中甲状腺激素受体α结合峰重叠;六个显著CpG位点甲基化水平的总加性遗传力在25%至57%之间;在KLF9、FKBP5、LRRC8D和CSNK1D/LINC01970的CpG处鉴定到显著甲基化数量性状基因座。
关键数值与推荐
- 全表观基因组显著性阈值p值<1.1E-7。
- 合并p值范围1.5E-9至4.3E-28。
- 六个显著CpG位点甲基化水平的总加性遗传力在25%至57%之间。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Thyroid hormones play a key role in differentiation and metabolism and are known regulators of gene expression through both genomic and epigenetic processes including DNA methylation. The aim of this study was to examine associations between thyroid hormones and DNA methylation. Methods: We carried out a fixed-effect meta-analysis of epigenome-wide association study (EWAS) of blood DNA methylation sites from 8 cohorts from the ThyroidOmics Consortium, incorporating up to 7073 participants of both European and African ancestry, implementing a discovery and replication stage. Statistical analyses were conducted using normalized beta CpG values as dependent and log-transformed thyrotropin (TSH), free thyroxine, and free triiodothyronine levels, respectively, as independent variable in a linear model. The replicated findings were correlated with gene expression levels in whole blood and tested for causal influence of TSH and free thyroxine by two-sample Mendelian randomization (MR). Results: Epigenome-wide significant associations (p-value <1.1E-7) of three CpGs for free thyroxine, five for free triiodothyronine, and two for TSH concentrations were discovered and replicated (combined p-values = 1.5E-9 to 4.3E-28). The associations included CpG sites annotated to KLF9 (cg00049440) and DOT1L (cg04173586) that overlap with all three traits, consistent with hypothalamic-pituitary-thyroid axis physiology. Significant associations were also found for CpGs in FKBP5 for free thyroxine, and at CSNK1D/LINCO1970 and LRRC8D for free triiodothyronine. MR analyses supported a causal effect of thyroid status on DNA methylation of KLF9. DNA methylation of cg00049440 in KLF9 was inversely correlated with KLF9 gene expression in blood. The CpG at CSNK1D/LINC01970 overlapped with thyroid hormone receptor alpha binding peaks in liver cells. The total additive heritability of the methylation levels of the six significant CpG sites was between 25% and 57%. Significant methylation QTLs were identified for CpGs at KLF9, FKBP5, LRRC8D, and CSNK1D/LINC01970. Conclusions: We report novel associations between TSH, thyroid hormones, and blood-based DNA methylation. This study advances our understanding of thyroid hormone action particularly related to KLF9 and serves as a proof-of-concept that integrations of EWAS with other -omics data can provide a valuable tool for unraveling thyroid hormone signaling in humans by complementing and feeding classical in vitro and animal studies.
引用
- Weihs A, Chaker L, Martin TC, et al. Epigenome-Wide Association Study Reveals CpG Sites Associated with Thyroid Function and Regulatory Effects on KLF9. Thyroid. 2023. PMID: 36719767. doi:10.1089/thy.2022.0373
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。